Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
• The company is expanding its United States presence as it pursues commercial opportunities for its specialist technology.
• Star Combo Pharma disclosures mention its FY26 full-year reporting as part of its recent reporting record as described in the available information.
It is too early to say whetherLeadershipalone will alter the company's trajectory, and the financial evidence below shows why caution is reasonable.
Pro Medicus develops and licenses medical imaging software. Its United States subsidiary, Visage Imaging, sells the Visage 7 platform, which includes a viewer, a workflow tool and an open archive, with cardiology imaging added for some clients.
Sigma Healthcare (ASX:SIG) combines a pharmaceutical wholesaling and distributionBusinesswith the Chemist Warehouse retail andFranchisenetwork, following theMergercompleted in 2025. It supplies medicines and health products to pharmacies across Australia, operates and supports Chemist Warehouse branded stores, and also runs the Amcal and Discount Drug Stores …
Cryopreservation is the core of Vitrafy’s life-sciences offering. Its focus gives the company a defined position in a market where handling and preserving biological material is an important part of research and therapeutic processes. The company has been developing its technology while pursuing a …
• Company updates describe placements at major US hospital sites in the company’s disclosed business and operational updates.
The executive has more than 25 years' experience across the clinical trial ecosystem, including investigator sites, research governance and global pharmaceutical and biotechnology organisations. Most recently, the executive worked at a clinical-stage biotechnology company responsible for clinical research across Phase I to III studies.
The third blood partnership, announced on 30 September 2026, was with Versiti Blood Health, a blood research organisation based in Milwaukee. Vitrafy will initially place two of its Guardion cryopreservation devices at Versiti's Blood Research Institute to advance development of no-wash platelet cryopreservation. Versiti …
Saluda Medical, Inc. (ASX:SLD) is a commercial-stage medical device company with a neuromodulation platform for chronic neurological conditions. Its first product is the Evoke System, a closed-loop spinal cord stimulator.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…